Start for $99No results? No chargeSame-day approvalNo price increases — everBuy now, pay later

7 Ozempic Alternatives, From Compounded Semaglutide to the New Pills

Ozempic is approved for type 2 diabetes, not weight loss. These seven alternatives are the treatments people actually weigh instead, from compounded semaglutide and tirzepatide to the two new daily pills, with the trial results behind each.

Clinically reviewed
Medically reviewed by Arbor Health TeamMedical Content Team7 min read

The top three

Prices are Arbor's monthly starting prices
Our pick
Compounded semaglutide vial

01  Compounded semaglutide

Most direct swap for Ozempic

02  Compounded tirzepatide

Most effect for the price

$149a month, starting price

03  Wegovy injection

FDA-approved version of the same drug

14.9%mean loss vs 2.4% on placebo, 68 weeks

Compounded is not FDA-approved. Compounded semaglutide and tirzepatide contain the same active molecules as the brands, but the FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.

Ozempic alternatives at a glance

Ozempic is semaglutide, and its FDA label covers blood sugar control and heart and kidney risk in adults with type 2 diabetes. It is not approved for weight management. So an Ozempic alternative usually means one of two things: the same molecule in a weight-management form, or a different medication that works the same way.

The alternatives to Ozempic below fall into three groups: compounded semaglutide and tirzepatide, FDA-approved brand injections, and the newer daily pills. Each needs a prescription and is approved or prescribed alongside a reduced-calorie diet and more activity. The FDA notice FDA approves chronic weight management medication for tirzepatide dates only to November 2023.

Fit comes before cost. The right alternative to Ozempic depends on your health history, your preference for a shot or a pill, and a clinician's judgment.

Prescription Ozempic alternatives compared

Each of these Ozempic alternatives carries the trial result from its FDA label. For the compounded options, the numbers belong to the molecule. Among Ozempic alternatives for weight loss, the weekly injections lead on average loss, and the pills give up some of that for convenience.

  • Compounded semaglutide — How it is taken: Weekly injection; Label trial result: Molecule: 14.9% vs 2.4%; Length: 68 weeks
  • Compounded tirzepatide — How it is taken: Weekly injection; Label trial result: Molecule: 20.9% vs 3.1%; Length: 72 weeks
  • Wegovy injection — How it is taken: Weekly injection; Label trial result: 14.9% vs 2.4%; Length: 68 weeks
  • Zepbound injection — How it is taken: Weekly injection; Label trial result: 20.9% vs 3.1%; Length: 72 weeks
  • Wegovy pill — How it is taken: Daily tablet, empty stomach; Label trial result: 13.6% vs 2.4%; Length: 64 weeks
  • Foundayo — How it is taken: Daily pill, with or without food; Label trial result: 11.1% vs 2.1%; Length: 72 weeks
  • Liraglutide (Saxenda) — How it is taken: Daily injection; Label trial result: 7.4% vs 3.0%; Length: 56 weeks

Mean percent weight change vs placebo on the highest studied dose, from each FDA label. Compounded products have no trials of their own. Individual results vary.

If you want a pill alternative to Ozempic, there are two, and they work differently. An alternative to Ozempic for weight loss can also be the same drug at a lower monthly cost, through compounding.

Compounded semaglutide vial
01

Compounded semaglutide

Ozempic's molecule, compounded, not FDA-approved

$99a month, starting price

Compounded semaglutide is the same active ingredient as Ozempic and Wegovy, prepared by a licensed U.S. pharmacy for an individual prescription. Of every option here, it costs the least.

Where it wins

  • Same molecule behind the 14.9% STEP 1 result
  • Weekly injection, like Ozempic
  • Flat monthly price, with no increase as the dose changes

What it costs you

  • Not FDA-approved, and not reviewed by the FDA for safety, effectiveness or quality
  • Your clinician sets the dose, often drawn from a vial with a syringe
  • No trials of the compounded product itself

Most direct swap for Ozempic

02

Compounded tirzepatide

Zepbound's molecule, compounded, not FDA-approved

$149a month, starting price

Compounded tirzepatide contains the molecule in Zepbound, which acts on two receptors, GIP and GLP-1. In its label trial, that molecule produced the largest average loss of any option here.

Where it wins

  • Same molecule behind the 20.9% SURMOUNT-1 result
  • Weekly injection
  • A step up if you want more effect than semaglutide

What it costs you

  • Not FDA-approved
  • Costs more than compounded semaglutide
  • Nausea and diarrhea are common while the dose climbs

Most effect for the price

03

Wegovy injection

Semaglutide 2.4 mg, FDA-approved for weight

14.9%mean loss vs 2.4% on placebo, 68 weeks

Wegovy is semaglutide approved for chronic weight management, the brand most people mean when they ask about Ozempic for weight loss. It is also approved to lower heart attack and stroke risk in adults with heart disease and excess weight.

Where it wins

  • FDA-approved for weight management since 2021
  • Cardiovascular risk reduction shown in the SELECT trial
  • Approved for teens 12 and older

What it costs you

  • Boxed warning for thyroid C-cell tumors seen in rodents
  • Brand pricing and insurance coverage vary
  • Weekly injection

FDA-approved version of the same drug

04

Zepbound injection

Tirzepatide, FDA-approved for weight

20.9%mean loss at 15 mg, 72 weeks

Zepbound is tirzepatide, approved for chronic weight management in November 2023 and for moderate to severe obstructive sleep apnea in adults with obesity in December 2024.

Where it wins

  • Largest mean loss in its label trial
  • Also approved for sleep apnea with obesity
  • Weekly injection

What it costs you

  • Same thyroid C-cell boxed warning
  • Brand pricing and coverage vary
  • Adults only

Strongest FDA-approved option

05

The Wegovy pill

Oral semaglutide 25 mg, once daily

13.6%mean loss vs 2.4% on placebo, 64 weeks

Approved in December 2025, the Wegovy pill is semaglutide as a daily tablet for weight management and heart risk reduction in adults. Its trial result sits close to the injection's.

Where it wins

  • No needles
  • Semaglutide, the molecule in Ozempic
  • Heart risk reduction indication, like the injection

What it costs you

  • Taken on an empty stomach with up to 4 ounces of water
  • Then a 30 minute wait before any food, drink or other pills
  • Adults only

Best pill if a morning routine suits you

06

Foundayo, a daily oral pill

Orforglipron, approved April 2026

11.1%mean loss at 17.2 mg, 72 weeks

Foundayo is orforglipron, a GLP-1 pill the FDA approved on April 1, 2026. You can take it with or without food, which removes the fasting step the Wegovy pill needs.

Where it wins

  • No empty-stomach rule
  • No needles
  • 11.1% vs 2.1% on placebo in its label trial

What it costs you

  • Less average loss than the injections
  • Newest option, shortest real-world record
  • Dose rises over several steps at least 30 days apart

Simplest daily pill

07

Liraglutide & Saxenda

Daily GLP-1 injection, generic available

7.4%mean loss vs 3.0% on placebo, 56 weeks

Liraglutide was the first GLP-1 approved for weight management, as Saxenda in 2014. An FDA-approved generic followed in August 2025.

Where it wins

  • Generic version available
  • Approved for teens 12 and older
  • On the market for weight since 2014

What it costs you

  • Daily injections
  • About half the average loss of semaglutide
  • Label says to stop if you have not lost 4% by week 16

Generic option, with trade-offs

Tirzepatide vial
Weight lossTirzepatide

Dual-action GLP‑1/GIP for faster results

From
$149/mo
Taken
Once-weekly injection
Type
Dual GLP‑1/GIP agonist
Learn more

How to choose an Ozempic alternative

There is no single best alternative to Ozempic. Your health history narrows the field first: a personal or family history of medullary thyroid cancer or MEN 2 rules out every GLP-1 here, and plans for pregnancy change the conversation. Then come three choices.

  1. Injection or pill. The table above shows the gap in average loss. Pills skip needles but add a daily routine.
  2. FDA-approved brand or compounded. Brands carry FDA review. Compounded versions contain the same molecules but are not FDA-approved.
  3. What you can sustain. A treatment works only while you take it, so yearly cost matters.

For a cheaper alternative to Ozempic, compounded semaglutide is the most direct option, and compounded semaglutide vs Ozempic lays out the trade-offs. Arbor's clinicians review every intake. If a medication is not the right fit, it is not prescribed. To see whether one fits you, get started with Arbor.

Severe stomach pain that sometimes spreads to your back, with or without vomiting, can be a sign of pancreatitis: stop the medication and get medical care. Trouble breathing or swelling of the face or throat is an emergency. For anything else, message your Arbor clinician before changing a dose.

Frequently asked questions

What is a cheaper alternative to Ozempic depends on your coverage. Compounded semaglutide, the same molecule, starts at $99 a month at Arbor. It is not FDA-approved. Generic liraglutide is another lower-cost route.

No food or supplement works like Ozempic. Natural alternatives to Ozempic such as berberine show small effects at best: very little berberine may be absorbed by mouth, and a recent meta-analysis found average weight loss under 1 kg. Some foods raise your own GLP-1, but only for a few hours.

No GLP-1 is sold over the counter. Among Ozempic alternatives over the counter, orlistat 60 mg (Alli) is an FDA-approved weight-loss drug sold without a prescription. Dietary supplements get no FDA approval before sale.

Sources

  1. Ozempic (semaglutide) label, DailyMed.
  2. Wegovy (semaglutide) injection and tablets label, DailyMed.
  3. Wegovy tablets NDA 218316 approval history, Drugs@FDA.
  4. Zepbound (tirzepatide) label, DailyMed.
  5. FDA approves new medication for chronic weight management, November 8, 2023.
  6. FDA approves first medication for obstructive sleep apnea, December 20, 2024.
  7. FDA approves Foundayo (orforglipron), April 1, 2026.
  8. Saxenda (liraglutide) label, DailyMed.
  9. Generic liraglutide ANDA 214568 approval history, Drugs@FDA.
  10. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med. 2021.
  11. Jastreboff AM et al. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). N Engl J Med. 2022.
  12. FDA's concerns with unapproved GLP-1 drugs used for weight loss.
  13. Alli (orlistat 60 mg) Drug Facts, DailyMed.
  14. Goldenseal (berberine), NCCIH.
  15. Elahi Vahed I et al. Berberine and body weight: meta-analysis. Int J Obes. 2026.
  16. FDA 101: Dietary supplements.
  • GLP-1 Medications

    Most hair loss on a GLP-1 looks like shedding after fast weight loss, and it usually grows back. What people call Ozempic hair loss shows up in the semaglutide and tirzepatide prescribing data too, at rates of 3% to 6% in trials. Here is what causes it, what lowers your odds, and when to raise it with Arbor's clinicians.

    By Arbor Health Team

  • GLP-1 Medications

    Natural GLP-1 foods are real, but their effect is measured in minutes and percentages, not weeks. Here are 12 foods studied for GLP-1 in people, ranked by how strong the evidence is, and an honest look at why none of them works like Ozempic.

    By Arbor Health Team